{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:02:39Z","timestamp":1745748159813},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1255-0","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T11:24:58Z","timestamp":1435231498000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood"],"prefix":"10.1186","volume":"8","author":[{"given":"Marinus J","family":"Dekkers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap W","family":"Groothoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zietse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel G H","family":"Betjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"key":"1255_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1978.23","volume":"13","author":"HL Barnett","year":"1978","unstructured":"Barnett HL, Edelman CM, Greifer I, Spitzer A, Freeman K, Arneil GC et al (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159\u2013165","journal-title":"Kidney Int"},{"key":"1255_CR2","doi-asserted-by":"crossref","unstructured":"Hodson EM, Knight JF, Willis NS, Craig JC (2003) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev CD001533","DOI":"10.1002\/14651858.CD001533.pub2"},{"key":"1255_CR3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00467-011-1837-6","volume":"26","author":"ST Esfahani","year":"2011","unstructured":"Esfahani ST, Madani A, Asgharian F, Ataei N, Roohi A, Moghtaderi A et al (2011) Clinical course and outcome of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 26:1089\u20131093","journal-title":"Pediatr Nephrol"},{"key":"1255_CR4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","volume":"4","author":"HAC Kyrieleis","year":"2009","unstructured":"Kyrieleis HAC, L\u00f6wik MM, Pronk I, Cruysberg HR, Kremer JA, Oven WJ et al (2009) Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol 4:1593\u20131600","journal-title":"Clin J Am Soc Nephrol"},{"key":"1255_CR5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2009","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afenetti M et al (2009) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269\u20131279","journal-title":"Pediatr Nephrol"},{"key":"1255_CR6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"AL Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Gu\u00e9rin V, Lapillonne H et al (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood- follow-up after CD19 recovery. Nephrol Dial Transplant 27:1083\u20131089","journal-title":"Nephrol Dial Transplant"},{"key":"1255_CR7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","volume":"24","author":"K Kamei","year":"2009","unstructured":"Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M et al (2009) Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 24:1321\u20131328","journal-title":"Pediatr Nephrol"},{"key":"1255_CR8","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","volume":"84","author":"P Ravani","year":"2013","unstructured":"Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F (2013) Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int 84:1025\u20131033","journal-title":"Kidney Int"},{"key":"1255_CR9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","volume":"49","author":"H Fran\u00e7ois","year":"2007","unstructured":"Fran\u00e7ois H, Daugas E, Bensman A, Ronco P (2007) Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis 49:158\u2013161","journal-title":"Am J Kidney Dis"},{"key":"1255_CR10","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/ndt\/gfm128","volume":"22","author":"JM Hofstra","year":"2007","unstructured":"Hofstra JM, Deegens JKJ, Wetzels JFM (2007) Rituximab: effective for severe steroid-dependent minimal change nephrotic syndrome? Nephrol Dial Transplant 22:2100\u20132101","journal-title":"Nephrol Dial Transplant"},{"key":"1255_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP72069","volume":"72","author":"Y Sawara","year":"2009","unstructured":"Sawara Y, Itabashi M, Kojima C, Tabata H, Kamei D, Kawanishi K et al (2009) Succesful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome. Clin Nephrol 72:69\u201372","journal-title":"Clin Nephrol"},{"key":"1255_CR12","first-page":"308","volume":"74","author":"A Beco","year":"2010","unstructured":"Beco A, Castro-Ferreira I, Coentrao L, Neto R, Sampaio S, Pestana M (2010) Rituximab for steroid-dependent nephrotic syndrome. Clin Nephrol 74:308\u2013310","journal-title":"Clin Nephrol"},{"key":"1255_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5414\/CN107092","volume":"76","author":"E Hoxha","year":"2011","unstructured":"Hoxha E, Stahl RA, Harendza S (2011) Rituximab in adult patients with immunosuppressive-dependent minimal change disease. Clin Nephrol 76:151\u2013158","journal-title":"Clin Nephrol"},{"key":"1255_CR14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2012.444","volume":"83","author":"H Munyentwali","year":"2013","unstructured":"Munyentwali H, Bouachi K, Audard V, Rwemy P, Lang P, Mojaat R et al (2013) Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. Kidney Int 83:511\u2013516","journal-title":"Kidney Int"},{"key":"1255_CR15","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/ndt\/gfs515","volume":"28","author":"T Takei","year":"2013","unstructured":"Takei T, Itabsahi M, Moriyama T, Jojima C, Shiohira S, Shimizu A et al (2013) Effect of single-dose rituximab on steroid-dependent minimal change nephrotic syndrome in adults. Nephrol Dial Transplant 28:1225\u20131232","journal-title":"Nephrol Dial Transplant"},{"key":"1255_CR16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2013030251","volume":"25","author":"P Ruggenenti","year":"2014","unstructured":"ADD 3, Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Maras\u00e0 M (2014) Rituximab in steroid-dependent or frequently relasping idiopathic nephrotic syndrome. J Am Soc Nephrol 25:850\u2013863","journal-title":"J Am Soc Nephrol"},{"key":"1255_CR17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/01.smj.0000243183.87381.c2","volume":"99","author":"TC Saha","year":"2006","unstructured":"Saha TC, Singh H (2006) Minimal change disease: a review. South Med J 99:1264\u20131270","journal-title":"South Med J"},{"key":"1255_CR18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/adc.57.7.544","volume":"57","author":"O Koskimies","year":"1982","unstructured":"Koskimies O, Vilska J, Rapola J, Hallman N (1982) Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57:544\u2013548","journal-title":"Arch Dis Child"},{"key":"1255_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G et al (2007) Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2:445\u2013453","journal-title":"Clin J Am Soc Nephrol"},{"key":"1255_CR20","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","volume":"23","author":"EM Dorresteijn","year":"2008","unstructured":"Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ (2008) Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 23:2013\u20132020","journal-title":"Pediatr Nephrol"},{"key":"1255_CR21","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1046\/j.1523-1755.2001.0590051919.x","volume":"59","author":"AM Durkan","year":"2001","unstructured":"Durkan AM, Hodson EM, Willis NS, Craig JC (2001) Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials. Kidney Int 59:1919\u20131927","journal-title":"Kidney Int"},{"key":"1255_CR22","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","volume":"11","author":"SK Mak","year":"1996","unstructured":"Mak SK, Short CD, Mallcik NP (1996) Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Transplant 11:2192\u20132201","journal-title":"Nephrol Dial Transplant"},{"key":"1255_CR23","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","volume":"27","author":"MJ Kemper","year":"2012","unstructured":"Kemper MJ, Gellerman J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T et al (2012) Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant 27:1910\u20131915","journal-title":"Nephrol Dial Transplant"},{"key":"1255_CR24","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S et al (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207\u20132212","journal-title":"Clin J Am Soc Nephrol"},{"key":"1255_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00467-011-1997-4","volume":"27","author":"A Sinha","year":"2012","unstructured":"Sinha A, Bagga A, Gulati A, Hari P (2012) Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome. Pediatr Nephrol 27:235\u2013241","journal-title":"Pediatr Nephrol"},{"key":"1255_CR26","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","volume":"6","author":"P Ravani","year":"2011","unstructured":"Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L et al (2011) Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol 6:1308\u20131315","journal-title":"Clin J Am Soc Nephrol"},{"key":"1255_CR27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","volume":"23","author":"A Magnasco","year":"2012","unstructured":"Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M et al (2012) Rituximab in children with reistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23:1117\u20131124","journal-title":"J Am Soc Nephrol"},{"key":"1255_CR28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"7","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 7:556\u2013560","journal-title":"Lancet"},{"key":"1255_CR29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ndt\/18.2.245","volume":"18","author":"P Grimbert","year":"2003","unstructured":"Grimbert P, Audard V, Remy P, Lang P, Sahali D (2003) Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 18:245\u2013248","journal-title":"Nephrol Dial Transplant"},{"key":"1255_CR30","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","volume":"24","author":"C Araya","year":"2009","unstructured":"Araya C, Diaz L, Wasserfall C, Atkinson M, Mu W, Johnson R et al (2009) T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 24:1691\u20131698","journal-title":"Pediatr Nephrol"},{"key":"1255_CR31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2010-01-266668","volume":"116","author":"O Thaunat","year":"2010","unstructured":"Thaunat O, Morelon E, Defrance T (2010) Am \u201cB\u201d valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. Blood 116:515\u2013521","journal-title":"Blood"},{"key":"1255_CR32","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","volume":"110","author":"R Stasi","year":"2007","unstructured":"Stasi R, Del Poeta G, Stipa E, Evangelista ML, Abruzzese E, Amadori S (2007) Response to B-cell-depleting therapy with rituximab reverts the adnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood 110:2924\u20132930","journal-title":"Blood"},{"key":"1255_CR33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncprheum0983","volume":"5","author":"SK Datta","year":"2009","unstructured":"Datta SK (2009) Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T-cells. Nat Clin Pract Rheumatol 5:80\u201382","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1255_CR34","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Robier A-P, Jauregui AN (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med. doi: 10.1126\/scitranslmed.3002231","journal-title":"Sci Transl Med"},{"key":"1255_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2010.08076.x","volume":"149","author":"N Cooper","year":"2010","unstructured":"Cooper N, Arnold DM (2010) The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. Br J Haematol 149:3\u201313","journal-title":"Br J Haematol"},{"key":"1255_CR36","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1542\/peds.2009-3395","volume":"126","author":"DS Ardelean","year":"2010","unstructured":"Ardelean DS, Gonska T, Wires S, Cutz E, Griffiths A, Harvey E et al (2010) Severe ulcerative colitis after rituximab therapy. Pediatrics 126:e243\u2013e246","journal-title":"Pediatrics"},{"key":"1255_CR37","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00467-009-1195-9","volume":"24","author":"MC Chaumais","year":"2009","unstructured":"Chaumais MC, Garnier A, Chalard F, Peuchmaur M, Dauger S, Jacqz-Agrain E et al (2009) Fatal pulmonary fibrosis after rituximab administration. Pediatr Nephrol 24:1753\u20131755","journal-title":"Pediatr Nephrol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1255-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T14:31:14Z","timestamp":1498228274000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1255"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1255-0","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]},"article-number":"266"}}